Why PBM Reform, not MFN, is a Viable Path to Affordable Drug Access

More than half of American adults manage multiple chronic conditions. The prevalence is enough to strain the U.S. healthcare system and challenge patient access to new treatments. To compound the issue, pharmacy benefit managers (PBMs) and others siphon nearly half of every dollar spent on brand-name drugs, driving up costs for patients.

Read the full article on the Partnership to Fight Chronic Disease.